Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP1 Agonist at BIO 2024 New York, 05/16/2024 / 09:00, EST/EDT EQS Newswire Laxxon Medical
NEW YORK, NY / ACCESSWIRE / May 16, 2024 /... Lire le communiqué |
|
|
|
|
Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024 New York, 04/23/2024 / 16:40, EST/EDT EQS Newswire Laxxon Medical
Laxxon Medical, a leading 3D screen printing platform technology company, announced today its participation in the World Orphan Drug Congress USA 2024, taking place April 23... Lire le communiqué |
|
|
|
|
Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference New York, 03/28/2024 / 08:00, EST/EDT EQS Newswire Laxxon Medical
NEW YORK, NY / ACCESSWIRE / March 28, 2024 /... Lire le communiqué |
|
|
|
|
Laxxon Medical to Participate in 26th Annual Needham Growth Conference New York, 12/18/2023 / 08:00, EST/EDT EQS Newswire Laxxon Medical
NEW YORK, NY / ACCESSWIRE / December 18, 2023 / Laxxon Medical, a leading pharmatechnology company pioneering a new generation of advanced pharmaceuticals, tod... Lire le communiqué |
|
|
|
|
Laxxon Medical to Attend 42nd Annual J.P. Morgan Healthcare Conference in San Francisco New York, 12/06/2023 / 08:00, EST/EDT EQS Newswire Laxxon Medical
NEW YORK, NY / ACCESSWIRE / December 6, 2023 / Laxxon Medical announced today its attendance at the... Lire le communiqué |
|
|
|
|
Laxxon Medical joins German Accelerator’s Southeast Asia Market Access Class of 2023, marking the Company’s inaugural globalization venture New York, 11/16/2023 / 08:01, EST/EDT EQS Newswire Laxxon Medical
NEW YORK, NY / ACCESSWIRE / November 16, 2023 / Pharmaceutic... Lire le communiqué |
|
|
|
|
Laxxon Medical to Attend BIOEurope Munich 2023 New York, 11/06/2023 / 12:00, EST/EDT EQS Newswire Laxxon Medical
NEW YORK, NY / ACCESSWIRE / November 6, 2023 / Laxxon Medical announced today its participation in the 29th annual BIOEurope Convention, taking place No... Lire le communiqué |
|
|
|
|